Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease
Open accessPublished version of a preprint
The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
Background: Growth differentiation factor-15 (GDF-15) is a marker of inflammation, oxidative stress and it is associated with adverse prognosis in cardiovascular disease. The aim of the present cohort study is to investigate the prognostic value of GDF-15 in patients with coronary artery disease (CAD) during long-term follow up. Methods: A total of 3641 consecutive patients with CAD were prospectively enrolled into the study and followed up for major adverse cardiovascular events (MACEs) and all-cause death up to 5.3–7.6 years. Plasma GDF-15 was measured and clinical data and long-term events were registered. The patients were subsequently divided into three groups by the levels of GDF-15 and the prognostic value of GDF-15 level with MACEs and all-cause death was evaluated. Results: After a median follow-up at 6.4 years later, 775 patients (event rate of 21%) had developed MACEs and 275 patients died (event rate of 7.55%). Kaplan–Meier analysis indicated that the patients with GDF-15 > 1800 ng/L were significantly associated with an increased risk of MACEs and all-cause death. Cox regression analysis indicated that GDF-15 > 1800 ng/L were independently associated with the composite of MACEs (HR 1.74; 95% CI 1.44–2.02; P < 0.001) and all-cause death (HR 2.04; 95% CI 1.57–2.61; P < 0.001). For MACEs, GDF-15 significantly improved the C-statistic (area under the curve, 0.583 [95% CI 0.559–0.606] to 0.628 [0.605–0.651]; P < 0.001), net reclassification index (0.578; P = 0.031), and integrated discrimination index (0.021; P = 0.027). For all-cause death, GDF-15 significantly improved the C-statistic (0.728 [95% CI 0.694–0.761] to 0.817 [0.781–0.846]; P < 0.001), net reclassification index (0.629; P = 0.001), and integrated discrimination index (0.035; P = 0.002). Conclusions: In the setting of CAD, GDF-15 is associated with long-term MACEs and all-cause death, and provides incremental prognostic value beyond traditional risks factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a stress-responsive cytokine, GDF15 is elevated in many cardiac disorders and may reflect underlying valvular pathological processes driven by chronic inflammation and oxidative stress 26-28 .”
From Connecting proteomics and genomics to identify causal biomarkers specific for aortic valve stenosis (2025) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Journal of The American College of Cardiology
(2015) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2015.03.023 · Cited by 2,584
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
The Global Burden of Cardiovascular Diseases and Risk Factors
Mensah, G. A., Roth, G. A., & Fuster, V. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.009 · Cited by 1,324
European Society of Cardiology: Cardiovascular Disease Statistics 2017
Timmis, A., Petersen, S. E., Belle, E. V., Townsend, N. P., Conrad, N., Kaplon-Cieslicka, A., Kazakiewicz, D., Kavousi, M., Cvijic, M., Ignatiuk, B., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehag345 · Cited by 945
Widespread Coronary Inflammation in Unstable Angina
Buffon, A., Biasucci, L. M., Liuzzo, G., D'Onofrio, G., Crea, F., & Maseri, A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012295 · Cited by 922
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius, B., Berglund, L., Sundström, J., Ingelsson, E., Basu, S., Larsson, A., Venge, P., & Ärnlöv, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707064 · Cited by 889
Goff, D. C., Lloyd‐Jones, D. M., Bennett, G. C., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D. A., O’Donnell, C. J., et al. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 851
Low Serum Testosterone and Mortality in Older Men
Laughlin, G. A., Barrett-Connor, E., & Bergstrom, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1792 · Cited by 798
Horckmans, M., Ring, L., Duchene, J., Santovito, D., Schloss, M. J., Drechsler, M., Weber, C., Soehnlein, O., & Steffens, S. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw002 · Cited by 727 · cited 1×
“Moreover, inflammation is involved in cardiac muscle damage, neutrophils drive the early inflammatory response following a myocardial damage [23] and pro-inflammatory interleukins IL-6, IL-18 and MMP-12 are markers of preclinical cardiovascular organ damage [24].”
BackgroundChronic Heart Failure and Inflammation: What Do We Really Know?
Dick, S. A., & Epelman, S. (2016) · Circulation Research · doi:10.1161/circresaha.116.308030 · Cited by 692
Kempf, T., Eden, M., Strelau, J., Naguib, M., Willenbockel, C., Tongers, J., Heineke, J., Kotlarz, D., Xu, J., Molkentin, J. D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000202805.73038.48 · Cited by 651
Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral Inflammation
Wang, A., Huen, S. C., Luan, H. H., Yu, S., Zhang, C., Gallezot, J.-D., Booth, C. J., & Medzhitov, R. (2016) · Cell · doi:10.1016/j.cell.2016.07.026 · Cited by 579
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Wollert, K. C., Kempf, T., & Wallentin, L. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255174 · Cited by 559
CD14++CD16+ Monocytes Independently Predict Cardiovascular Events
Rogacev, K. S., Cremers, B., Zawada, A. M., Seiler, S., Binder, N., Ege, P., Große-Dunker, G., Heisel, I., Hornof, F., Jeken, J., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.019 · Cited by 535
GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance
Luan, H. H., Wang, A., Hilliard, B. K., Carvalho, F., Rosen, C. E., Ahasic, A. M., Herzog, E. L., Kang, I., Pisani, M. A., Yu, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.033 · Cited by 527
Kempf, T., Zarbock, A., Widera, C., Butz, S., Stadtmann, A., Rossaint, J., Bolomini-Vittori, M., Korf-Klingebiel, M., Napp, L. C., Hansen, B., et al. (2011) · Nature Medicine · doi:10.1038/nm.2354 · Cited by 518
Xu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506
Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure
Kempf, T., von Haehling, S., Peter, T., Allhoff, T., Cicoira, M., Doehner, W., Ponikowski, P., Filippatos, G. S., Rozentryt, P., Drexler, H., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.091 · Cited by 491
Wollert, K. C., Kempf, T., Peter, T., Olofsson, S., James, S., Johnston, N., Lindahl, B., Horn-Wichmann, R., Brabant, G., Simoons, M. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.650846 · Cited by 379
Journal of the American Heart Association
(2013) · Journal of the American Heart Association · doi:10.1002/(issn)2047-9980 · Cited by 366
Haring, R., Volzke, H., Steveling, A., Krebs, A., Felix, S. B., Schofl, C., Dorr, M., Nauck, M., & Wallaschofski, H. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq009 · Cited by 311
Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers
Koopmann, J., Buckhaults, P., Brown, D. A., Zahurak, M. L., Sato, N., Fukushima, N., Sokoll, L. J., Chan, D. W., Yeo, C. J., Hruban, R. H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0165 · Cited by 275
Protein Biomarkers of Cardiovascular Disease and Mortality in the Community
Ho, J. E., Lyass, A., Courchesne, P., Chen, G., Liu, C., Yin, X., Hwang, S., Massaro, J. M., Larson, M. G., & Levy, D. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008108 · Cited by 269 · cited 1×
“(GDF15) was associated with all cause death in the community [28].”
BackgroundTan, M., Wang, Y., Guan, K., & Sun, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.109 · Cited by 252
Daniels, L. B., Clopton, P., Laughlin, G. A., Maisel, A. S., & Barrett-Connor, E. (2011) · Circulation · doi:10.1161/circulationaha.110.979740 · Cited by 247
Kempf, T., Bjorklund, E., Olofsson, S., Lindahl, B., Allhoff, T., Peter, T., Tongers, J., Wollert, K. C., & Wallentin, L. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm465 · Cited by 227
Schlittenhardt, D., Schober, A., Strelau, J., Bonaterra, G. A., Schmiedt, W., Unsicker, K., Metz, J., & Kinscherf, R. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0986-3 · Cited by 224
Inflammation as a Possible Link Between Coronary and Carotid Plaque Instability
Lombardo, A., Biasucci, L. M., Lanza, G. A., Coli, S., Silvestri, P., Cianflone, D., Liuzzo, G., Burzotta, F., Crea, F., & Maseri, A. (2004) · Circulation · doi:10.1161/01.cir.0000130786.28008.56 · Cited by 222
Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
Khan, S. Q., Ng, K., Dhillon, O., Kelly, D., Quinn, P., Squire, I. B., Davies, J. E., & Ng, L. L. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn600 · Cited by 218
Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta
Lawton, L. N., Bonaldo, M. D. F., Jelenc, P. C., Qiu, L., Baumes, S. A., Marcelino, R. A., de Jesus, G. M., Wellington, S., Knowles, J. A., Warburton, D., et al. (1997) · Gene · doi:10.1016/s0378-1119(97)00485-x · Cited by 207
Rohatgi, A., Patel, P., Das, S. R., Ayers, C. R., Khera, A., Martinez-Rumayor, A., Berry, J. D., McGuire, D. K., & de Lemos, J. A. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.171926 · Cited by 178
Reduced oxidative capacity in macrophages results in systemic insulin resistance
Jung, S.-B., Choi, M. J., Ryu, D., Yi, H.-S., Lee, S. E., Chang, J. Y., Chung, H. K., Kim, Y. K., Kang, S. G., Lee, J. H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03998-z · Cited by 170
Bonaca, M. P., Morrow, D. A., Braunwald, E., Cannon, C. P., Jiang, S., Breher, S., Sabatine, M. S., Kempf, T., Wallentin, L., & Wollert, K. C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213512 · Cited by 167
Bauskin, A. R., Brown, D. A., Junankar, S., Rasiah, K. K., Eggleton, S., Hunter, M., Liu, T., Smith, D., Kuffner, T., Pankhurst, G. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3827 · Cited by 154
Lok, S. I., Winkens, B., Goldschmeding, R., van Geffen, A. J. P., Nous, F. M. A., van Kuik, J., van der Weide, P., Klöpping, C., Kirkels, J. H., Lahpor, J. R., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs120 · Cited by 153
Kempf, T., Sinning, J.-M., Quint, A., Bickel, C., Sinning, C., Wild, P. S., Schnabel, R., Lubos, E., Rupprecht, H. J., Münzel, T., et al. (2009) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.824870 · Cited by 131
Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond
Mullican, S. E., & Rangwala, S. M. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.05.002 · Cited by 127 · cited 1×
“associated with cardiovascular diseases such as hypertrophy [16], heart failure [17-19], atherosclerosis [20], endothelial dysfunction [21], obesity [22].”
BackgroundCirculating Proteins as Predictors of Incident Heart Failure in the Elderly
Stenemo, M., Nowak, C., Byberg, L., Sundström, J., Giedraitis, V., Lind, L., Ingelsson, E., Fall, T., & Ärnlöv, J. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.980 · Cited by 126 · cited 1×
“associated with cardiovascular diseases such as hypertrophy [16], heart failure [17-19], atherosclerosis [20], endothelial dysfunction [21], obesity [22].”
BackgroundHagström, E., Held, C., Stewart, R. A. H., Aylward, P. E., Budaj, A., Cannon, C. P., Koenig, W., Krug-Gourley, S., Mohler, E. R., Steg, P. G., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.260570 · Cited by 124
Abulizi, P., Loganathan, N., Zhao, D., Mele, T., Zhang, Y., Zwiep, T., Liu, K., & Zheng, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-00902-5 · Cited by 96
Bermudez, B., Lopez, S., Pacheco, Y. M., Villar, J., Muriana, F. J. G., Hoheisel, J. D., Bauer, A., & Abia, R. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn082 · Cited by 84
Bouabdallaoui, N., Claggett, B., Zile, M. R., McMurray, J. J. V., O'Meara, E., Packer, M., Prescott, M. F., Swedberg, K., Solomon, S. D., Rouleau, J. L., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1301 · Cited by 83
Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation
Kozàkovà, M., Morizzo, C., Gonçalves, I., Natali, A., Nilsson, J. Å., & Palombo, C. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0865-6 · Cited by 77
Andersson, C., Enserro, D., Sullivan, L., Wang, T. J., Januzzi, J. L., Benjamin, E. J., Vita, J. A., Hamburg, N. M., Larson, M. G., Mitchell, G. F., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.013 · Cited by 75 · cited 1×
“associated with cardiovascular diseases such as hypertrophy [16], heart failure [17-19], atherosclerosis [20], endothelial dysfunction [21], obesity [22].”
BackgroundLindholm, D., James, S. K., Gabrysch, K., Storey, R. F., Himmelmann, A., Cannon, C. P., Mahaffey, K. W., Steg, P. G., Held, C., Siegbahn, A., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.3811 · Cited by 73
Xu, X.-Y., Nie, Y., Wang, F.-F., Bai, Y., Lv, Z.-Z., Zhang, Y.-Y., Li, Z.-J., & Gao, W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.516278 · Cited by 65 · cited 1×
“associated with cardiovascular diseases such as hypertrophy [16], heart failure [17-19], atherosclerosis [20], endothelial dysfunction [21], obesity [22].”
BackgroundKimmoun, A., Cotter, G., Davison, B., Takagi, K., Addad, F., Celutkiene, J., Chioncel, O., Solal, A. C., Diaz, R., Damasceno, A., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1575 · Cited by 63 · cited 1×
“associated with cardiovascular diseases such as hypertrophy [16], heart failure [17-19], atherosclerosis [20], endothelial dysfunction [21], obesity [22].”
BackgroundElevated GDF-15 contributes to pulmonary inflammation upon cigarette smoke exposure
Verhamme, F. M., Seys, L., Smet, E. G. D., Provoost, S., Janssens, W., Elewaut, D. S., Joos, G., Brusselle, G., & Bracke, K. R. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.3 · Cited by 58
Sharma, A., Hijazi, Z., Andersson, U., Al‐Khatib, S. M., Lópes, R. D., Alexander, J. H., Held, C., Hylek, E. M., Leonardi, S., Hanna, M., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034125 · Cited by 57
Damman, P., Kempf, T., Windhausen, F., van Straalen, J. P., Guba‐Quint, A., Fischer, J., Tijssen, J. G. P., Wollert, K. C., de Winter, R. J., & Hirsch, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.01.025 · Cited by 45
Winzap, P., Davies, A., Klingenberg, R., Obeid, S., Roffi, M., Mach, F., Räber, L., Windecker, S., Templin, C., Nietlispach, F., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0946-6 · Cited by 45
Lu, W., Wan, Y., Li, Z., Zhu, B., Yin, C., Liu, H., Yang, S., Zhai, Y., Yu, Y., Wei, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0738-y · Cited by 45 · cited 1×
“It is highly expressed in cardio myocytes [11], adipocytes [12], macrophages [13], endothelial cells [14], and vascular smooth muscle cells [15] in normal and pathological condition.”
BackgroundSelf-citationKyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N. P., Abbastabar, H., Fayssoil, A., Abdela, J., & Abdelalim, A. (2018) · The Lancet · Cited by 41
Archives of cardiovascular diseases supplements
de cardiologie, S. F. (2009) · Cited by 22
Walter, J. E., Nestelberger, T., Boeddinghaus, J., Twerenbold, R., Croton, L., Badertscher, P., Wildi, K. S., Wussler, D. N., de Lavallaz, J. D. F., Mueller, C. E., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.04.088 · Cited by 14 · cited 1×
“The above studies shows that elevated GDF-15 has been shown to promote inflammation implying that GDF-15 may play an important role in the pathogenesis of atherosclerosis [25-27].”
BackgroundInvolvement of Cytokines and Inflammation in Catecholamine-Induced Pulmonary Injury in Rats
Raßler, B., Rohling, M. A., Reißig, C., Briest, W., Tannapfel, A., & Zimmer, H. (2005) · Vascular Disease Prevention · doi:10.2174/1567270000502010001 · Cited by 13
Liu, H., Lyu, Y., Li, D., Cui, Y., Huang, Y., Dai, W., & Li, Y. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0823-3 · Cited by 13
Self-citationGrowth differentiation factor 15 in cardiovascular diseases: Are we needed novel biomarker?
Alex, A., & Berezin, E. E. (2018) · Cited by 6
Méloux, Rochette, L., Maza, M., Bichât, F., Beer, J., Chague, F., Cottin, Y., Zeller, M., & Vergely, C. (2018) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/j.acvdsp.2018.10.096 · Cited by 4 · cited 3×
“Abbreviations GDF‑15: Growth differentiation factor‑15; CAD: Coronary artery disease; MACEs: Major adverse cardiovascular events; CV: Cardiovascular; MI: Myo‑ cardial infarction; AMI: Acute myocardial infarction; ACS: Acute coronary syndrome; STEMI: ST‑segment elevation myocardial infarction; M‑CSF: Macrophage colony…”
BackgroundInfluential
Cited by
Sjøberg, K. A., Sigvardsen, C. M., Alvarado-Diaz, A., Andersen, N. R., Larance, M., Seeley, R. J., Schjerling, P., Knudsen, J. G., Katzilieris‐Petras, G., Clemmensen, C., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.016 · Cited by 102
Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome
Katsioupa, M., Kourampi, I., Oikonomou, E. K., Tsigkou, V., Theofilis, P., Charalambous, G., Marinos, G., Gialamas, I., Zisimos, K., Anastasiou, A., et al. (2023) · Life · doi:10.3390/life13101992 · Cited by 90
“It is linked to cardiovascular disease and a range of other conditions such as inflammation, oxidative stress, and cellular stress [126].”
BackgroundOmar, M., Jensen, J., Kistorp, C., Højlund, K., Videbæk, L. M., Tuxen, C., Larsen, J. H., Andersen, C. F., Gustafsson, F., Køber, L., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01463-2 · Cited by 70
Sun, X., Duan, J., Gong, C., Feng, Y., Hu, J., Gu, R., & Xu, B. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025266 · Cited by 70
“22,23 Our results showed that A , ELISA analysis of inflammatory factor interleukin-1, interleukin-6, and tumor necrosis factor-α in murine plasma at the end point of experiment (n=8– 12 each group).”
From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction
Stătescu, C., Anghel, L., Tudurachi, B.-S., Tudurachi, A., Benchea, L.-C., & Sascău, R. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169168 · Cited by 59
Metadata
- Authors
- Li, M., Duan, L., Cai, Y.-L., Li, H.-Y., Hao, B.-C., Chen, J.-Q., & Liu, H.-B.
- Affiliations
- Chinese PLA General Hospital (CN)
- Venue
- Cardiovascular Diabetology
- Published
- 2020-08-03
- Volume
- 19
- Issue
- 1
- Pages
- 120-120
- ISSN
- 1475-2840 (ISSN-L)
- PMC
- PMC7398317
- OpenAlex
- W3047598126
- Cited by
- 71
- References
- 67
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 16 · 2023: 12 · 2022: 5 · 2021: 4 · 2020: 1
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cardiovascular Diabetology (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Key Projects of Logistics Scientific Research Project of Chinese PLA (17BJZ48)
- National Key Research Program of China (2017YFC0840103)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- growth differentiation factor 15, coronary artery disease, major adverse cardiovascular events, all-cause mortality, prognostic factors, inflammation, oxidative stress, risk stratification, risk reclassification, plasma biomarkers, long-term follow-up, cardiovascular risk prediction
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Risk Factors, Time Factors, Biomarkers, Risk Assessment, Growth Differentiation Factor 15
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.